We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$75.2B
AUM Growth
+$9.1B
Cap. Flow
+$1.81B
Cap. Flow %
2.4%
Top 10 Hldgs %
12.06%
Holding
4,018
New
612
Increased
1,577
Reduced
1,314
Closed
496

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$798M
2
NFLX icon
Netflix
NFLX
+$608M
3
UNH icon
UnitedHealth
UNH
+$517M
4
AAPL icon
Apple
AAPL
+$461M
5
GEV icon
GE Vernova
GEV
+$296M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Healthcare 15.8%
3 Consumer Discretionary 12.38%
4 Financials 11.53%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
3076
Xenon Pharmaceuticals
XENE
$6.09B
$269K ﹤0.01%
8,600
-146,100
-94% -$4.77M
STHO icon
3077
Star Holdings Shares of Beneficial Interest
STHO
$113M
$269K ﹤0.01%
34,399
+2,900
+9% +$20K
FPAY
3078
DELISTED
FlexShopper
FPAY
$269K ﹤0.01%
223,780
+43,002
+24% +$54.6K
DHC
3079
Diversified Healthcare Trust
DHC
$2.16B
$269K ﹤0.01%
75,000
+64,300
+601% +$186K
DRH icon
3080
Diamondrock Hospitality Co
DRH
$2.72B
$268K ﹤0.01%
+35,000
New +$261K
SMIN icon
3081
iShares MSCI India Small-Cap ETF
SMIN
$762M
$266K ﹤0.01%
+3,450
New +$248K
JBI icon
3082
Janus International
JBI
$723M
$266K ﹤0.01%
+32,700
New +$249K
WBTN
3083
WEBTOON Entertainment Inc
WBTN
$1.26B
$264K ﹤0.01%
29,066
+14,766
+103% +$128K
AVD icon
3084
American Vanguard Corp
AVD
$68.4M
$262K ﹤0.01%
66,752
+40,052
+150% +$167K
OS
3085
DELISTED
OneStream Inc
OS
$260K ﹤0.01%
+9,200
New +$229K
IYC icon
3086
iShares US Consumer Discretionary ETF
IYC
$1.22B
$259K ﹤0.01%
+2,600
New +$241K
KLRS
3087
Kalaris Therapeutics
KLRS
$82.6M
$258K ﹤0.01%
96,751
+77,500
+403% +$350K
CGCP icon
3088
Capital Group Core Plus Income ETF
CGCP
$8.4B
$257K ﹤0.01%
+11,400
New +$253K
BLIN icon
3089
Bridgeline Digital
BLIN
$14.4M
$256K ﹤0.01%
183,829
-14,700
-7% -$23.9K
DFEM icon
3090
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$8.81B
$255K ﹤0.01%
+8,600
New +$236K
NVDQ icon
3091
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$21.4M
$255K ﹤0.01%
+9,370
New +$462K
IMPP icon
3092
Imperial Petroleum
IMPP
$209M
$251K ﹤0.01%
81,600
+7,900
+11% +$21.7K
OLMA icon
3093
Olema Pharmaceuticals
OLMA
$988M
$250K ﹤0.01%
58,800
-5,800
-9% -$25.9K
BV icon
3094
BrightView Holdings
BV
$1.23B
$250K ﹤0.01%
15,000
-3,800
-20% -$56.8K
NRIX icon
3095
Nurix Therapeutics
NRIX
$2.38B
$249K ﹤0.01%
21,900
-37,600
-63% -$406K
BL icon
3096
BlackLine
BL
$1.93B
$249K ﹤0.01%
+4,400
New +$227K
TMHC
3097
DELISTED
Taylor Morrison
TMHC
$249K ﹤0.01%
4,053
-113,300
-97% -$6.58M
JAVA icon
3098
JPMorgan Active Value ETF
JAVA
$7.07B
$249K ﹤0.01%
+3,800
New +$237K
BLTE
3099
Belite Bio
BLTE
$6.32B
$248K ﹤0.01%
+4,300
New +$262K
GLSI icon
3100
Greenwich LifeSciences
GLSI
$198M
$248K ﹤0.01%
27,300
+14,800
+118% +$141K

Similar funds

Renaissance Technologies's Q2 2025 Portfolio in Review

As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
  • Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
  • Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
  • Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
  • Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
  • Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.